Citeline Analytics - Transform trial, drug and site data into actionable insight
Transform trial, drug and site data into actionable insight
Discuss your projectCiteline Analytics delivers customized research and analysis that transforms information on clinical trials, drugs and sites into actionable intelligence for your organization.
From helping you to visualize your future competitive landscape to improving your chances of running a successful trial, this service provides the guidance you need for effective, efficient decision-making.
Make better strategic decisions
Citeline Analytics transforms large, complex bodies of intelligence into highly usable formats that support your strategic decision-making.
Apply trusted intelligence
By harnessing the skills of our expert team of industry analysts, Citeline Analytics ensures you get the right interpretation of complex biopharma intelligence, focusing on its implications and opportunities for your organization.
Get tailored support
Citeline Analytics works in partnership with you to define your project and provide the best solution for your business question. We offer post-delivery support with every project to ensure you realize the maximum benefit from your deliverables.
Make a lasting impression
Citeline Analytics projects are delivered in Microsoft Excel or PowerPoint so you can easily incorporate them into your presentations and proposals.
We loved the outcome of this project. This is incredibly valuable and your team was wonderful to work with. Citeline understood the assets that we needed and were able to work with us in a consultative manner to provide exactly what we needed.
Associate Director, Global Health Economics & Outcomes Research, Top 10 Pharma Company
Contact us today to discuss your current projects
Meet our experts
Our expert analyst team is on hand to help with your Citeline Analytics projects.
Susan Danheiser
Senior Director, Oncology & Analytics
Claire Herman
Senior Analyst, Autoimmune-Inflammation
Cydney Brooks
Senior Director, Editorial Projects
Daphna Halpern
Director, Oncology